Blog

PD-L1 in Cancer Immunotherapy: Insights from Recent ResearchRecent advancements in cancer immunotherapy have underscored the critical role of programmed death-ligand 1 (PD-L1) in mediating immune evasion by tumors. This article delves into how PD-L1 expression influences T-cell mediated immune evasion in cancer, contributing to improved biomarker targeting for immunotherapy. By exploring the molecular mechanisms, clinical implications, and future directions of PD-L1 research, we aim to provide a comprehensive understanding of its significance in the evolving landscape of cancer treatment.Introduction to PD-L1PD-L1, a protein expressed on the surface of various cells, plays a pivotal role in …